Advertisement
News

Benefits outweigh risks for Johnson and Johnson vaccine - EMA

Apr 20, 2021 16:01 By Shannonside News
Benefits outweigh risks for Johnson and Johnson vaccine - EMA
Share this article

The European medicines Agency has outlined its reason for the continued use of the vaccine this afternoon

Europe's Health regulator says unusual blood clots should be listed as very rare side effects of the Johnson and Johnson covid vaccine.

The European Medicines Agency says the overall benefits of the vaccine outweigh the risks.

In a statement, the EMA says it took into consideration all the data currently available, with eight reports of serious cases of unusual blood clots in the US, one of whom died.

Advertisement

The cases reviewed were very similar to the cases that occurred with the COVID-19 vaccine developed by AstraZeneca.

As of April 13th, over 7 million people had received the one-shot jab in the states.

Tags used in this article
Share this article
Advertisement
Advertisement

Shannonside Newsletter

Sign up now to keep up to date with the latest news.

Processing your request...

You are subscribed now! please check your email to confirm your subscription.

Copyright © 2024 Shannonside FM. Developed by Square1 and Powered by PublisherPlus